These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32064364)

  • 21. Contributions of liquid chromatography-mass spectrometry to "highlights" of biomedical research.
    Gelpí E
    J Chromatogr A; 2003 Jun; 1000(1-2):567-81. PubMed ID: 12877189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid chromatography tandem mass spectrometry in the clinical laboratory.
    Adaway JE; Keevil BG; Owen LJ
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):18-38. PubMed ID: 25313226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and novel rapid diagnostics that are impacting infection prevention and antimicrobial stewardship.
    Sullivan KV; Dien Bard J
    Curr Opin Infect Dis; 2019 Aug; 32(4):356-364. PubMed ID: 31135388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered metabolism and newborn screening using tandem mass spectrometry: lessons learned from the bench to bedside.
    Chace DH; Spitzer AR
    Curr Pharm Biotechnol; 2011 Jul; 12(7):965-75. PubMed ID: 21466463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in blood culture diagnostics: a fast and effective approach.
    Klein S; Zimmermann S; Köhler C; Mischnik A; Alle W; Bode KA
    J Med Microbiol; 2012 Mar; 61(Pt 3):323-331. PubMed ID: 22074848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of automation on mass spectrometry.
    Zhang YV; Rockwood A
    Clin Chim Acta; 2015 Oct; 450():298-303. PubMed ID: 26341893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS; Jakubowski N
    Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and biomarker-based diagnostics in early sepsis: current challenges and future perspectives.
    Schenz J; Weigand MA; Uhle F
    Expert Rev Mol Diagn; 2019 Dec; 19(12):1069-1078. PubMed ID: 31608730
    [No Abstract]   [Full Text] [Related]  

  • 29. Mass spectrometry-based clinical proteomics.
    Pusch W; Flocco MT; Leung SM; Thiele H; Kostrzewa M
    Pharmacogenomics; 2003 Jul; 4(4):463-76. PubMed ID: 12831324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and future developments of LC-MS/MS in clinical chemistry for quantification of biogenic amines.
    de Jong WH; de Vries EG; Kema IP
    Clin Biochem; 2011 Jan; 44(1):95-103. PubMed ID: 20627097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of diagnostic gene-expression microarrays: bridging the gap between bench and bedside.
    Roepman P
    Bioanalysis; 2010 Feb; 2(2):249-62. PubMed ID: 21083308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of Methotrexate in Human Serum and Plasma by Liquid Chromatography Tandem Mass Spectrometry.
    Winston-McPherson GN; Schmeling M; Hoofnagle AN
    Methods Mol Biol; 2019; 1872():101-110. PubMed ID: 30350283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A decade of HPLC-MS/MS in the routine clinical laboratory--goals for further developments.
    Vogeser M; Seger C
    Clin Biochem; 2008 Jun; 41(9):649-62. PubMed ID: 18374660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
    Stepczynska A; Schanstra JP; Mischak H
    Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the routine application of MALDI-TOF MS in clinical microbiology.
    Welker M; Van Belkum A; Girard V; Charrier JP; Pincus D
    Expert Rev Proteomics; 2019 Aug; 16(8):695-710. PubMed ID: 31315000
    [No Abstract]   [Full Text] [Related]  

  • 36. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in real-time PCR: application to clinical laboratory diagnostics.
    Kaltenboeck B; Wang C
    Adv Clin Chem; 2005; 40():219-59. PubMed ID: 16355924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances and New Perspectives in Capillary Electrophoresis-Mass Spectrometry for Single Cell "Omics".
    DeLaney K; Sauer CS; Vu NQ; Li L
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30583525
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.